APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liraglutide Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liraglutide Injection Market Outlook and Growth Opportunities 2026

26 December 2025198 pages

Choose your research edition.

Industry ResearchLiraglutide Injection Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Liraglutide Injection Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Liraglutide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liraglutide Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Liraglutide Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Liraglutide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liraglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liraglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liraglutide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liraglutide Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liraglutide Injection market include Novo Nordisk. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Liraglutide Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liraglutide Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liraglutide Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liraglutide Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Liraglutide Injection Segment by Company

Novo Nordisk

Liraglutide Injection Segment by Type

Type II

Type II

Liraglutide Injection Segment by Application

Hospital

Clinic

Liraglutide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liraglutide Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Liraglutide Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liraglutide Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Liraglutide Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liraglutide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liraglutide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liraglutide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Liraglutide Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liraglutide Injection industry.

Chapter 3: Detailed analysis of Liraglutide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Liraglutide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Liraglutide Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liraglutide Injection Industry Trends Table 2. Liraglutide Injection Industry Drivers Table 3. Liraglutide Injection Industry Opportunities and Challenges Table 4. Liraglutide Injection Industry Restraints Table 5. Global Liraglutide Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liraglutide Injection Revenue Share by Company (2021-2026) Table 7. Global Liraglutide Injection Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Liraglutide Injection Sales Volume Share by Company (2021-2026) Table 9. Global Liraglutide Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Liraglutide Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Liraglutide Injection Key Company Manufacturing Base & Headquarters Table 12. Global Liraglutide Injection Company, Product Type & Application Table 13. Global Liraglutide Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Liraglutide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Type II Table 18. Significant Companies of Type II Table 19. Global Liraglutide Injection Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Liraglutide Injection Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Liraglutide Injection Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Liraglutide Injection Sales Volume Share by Type (2021-2026) Table 23. Global Liraglutide Injection Sales Volume Share by Type (2027-2032) Table 24. Global Liraglutide Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Liraglutide Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Liraglutide Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Liraglutide Injection Sales Value Share by Type (2021-2026) Table 28. Global Liraglutide Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Liraglutide Injection Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Liraglutide Injection Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Liraglutide Injection Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Liraglutide Injection Sales Volume Share by Application (2021-2026) Table 35. Global Liraglutide Injection Sales Volume Share by Application (2027-2032) Table 36. Global Liraglutide Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Liraglutide Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Liraglutide Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Liraglutide Injection Sales Value Share by Application (2021-2026) Table 40. Global Liraglutide Injection Sales Value Share by Application (2027-2032) Table 41. Global Liraglutide Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Liraglutide Injection Sales by Region (2021-2026) & (W Units) Table 43. Global Liraglutide Injection Sales Market Share by Region (2021-2026) Table 44. Global Liraglutide Injection Sales by Region (2027-2032) & (W Units) Table 45. Global Liraglutide Injection Sales Market Share by Region (2027-2032) Table 46. Global Liraglutide Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Liraglutide Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Liraglutide Injection Sales Value Share by Region (2021-2026) Table 49. Global Liraglutide Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Liraglutide Injection Sales Value Share by Region (2027-2032) Table 51. Global Liraglutide Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Liraglutide Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Liraglutide Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Liraglutide Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Liraglutide Injection Sales by Country (2021-2026) & (W Units) Table 56. Global Liraglutide Injection Sales Market Share by Country (2021-2026) Table 57. Global Liraglutide Injection Sales by Country (2027-2032) & (W Units) Table 58. Global Liraglutide Injection Sales Market Share by Country (2027-2032) Table 59. Global Liraglutide Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Liraglutide Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Liraglutide Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Liraglutide Injection Sales Value Market Share by Country (2027-2032) Table 63. Novo Nordisk Company Information Table 64. Novo Nordisk Business Overview Table 65. Novo Nordisk Liraglutide Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Novo Nordisk Liraglutide Injection Product Portfolio Table 67. Novo Nordisk Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Liraglutide Injection Distributors List Table 71. Liraglutide Injection Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Liraglutide Injection Product Image Figure 2. Global Liraglutide Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liraglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Liraglutide Injection Sales (2021-2032) & (W Units) Figure 5. Global Liraglutide Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Liraglutide Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Type II Image Figure 10. Type II Image Figure 11. Global Liraglutide Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Liraglutide Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Liraglutide Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Liraglutide Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Liraglutide Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Liraglutide Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Liraglutide Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Liraglutide Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Liraglutide Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Liraglutide Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Liraglutide Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Liraglutide Injection Sales Value Share by Application (2021-2032) Figure 25. Global Liraglutide Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Liraglutide Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Liraglutide Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Liraglutide Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Liraglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Liraglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Liraglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Liraglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Liraglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Liraglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Liraglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Liraglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Liraglutide Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Liraglutide Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Liraglutide Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Liraglutide Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Liraglutide Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Liraglutide Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Liraglutide Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Type II
  • Type II
Applications
  • Hospital
  • Clinic
Companies covered
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liraglutide Injection Sales Value (2021-2032)
  4. 1.2.2 Global Liraglutide Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Liraglutide Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Liraglutide Injection Market Dynamics
  1. 2.1 Liraglutide Injection Industry Trends
  2. 2.2 Liraglutide Injection Industry Drivers
  3. 2.3 Liraglutide Injection Industry Opportunities and Challenges
  4. 2.4 Liraglutide Injection Industry Restraints
3 Liraglutide Injection Market by Company
  1. 3.1 Global Liraglutide Injection Company Revenue Ranking in 2025
  2. 3.2 Global Liraglutide Injection Revenue by Company (2021-2026)
  3. 3.3 Global Liraglutide Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Liraglutide Injection Average Price by Company (2021-2026)
  5. 3.5 Global Liraglutide Injection Company Ranking (2024-2026)
  6. 3.6 Global Liraglutide Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Liraglutide Injection Company Product Type and Application
  8. 3.8 Global Liraglutide Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Liraglutide Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Liraglutide Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Liraglutide Injection Market by Type
  1. 4.1 Liraglutide Injection Type Introduction
  2. 4.1.1 Type II
  3. 4.1.2
  4. 4.2 Global Liraglutide Injection Sales Volume by Type
  5. 4.2.1 Global Liraglutide Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liraglutide Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Liraglutide Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Liraglutide Injection Sales Value by Type
  9. 4.3.1 Global Liraglutide Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Liraglutide Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Liraglutide Injection Sales Value Share by Type (2021-2032)
5 Liraglutide Injection Market by Application
  1. 5.1 Liraglutide Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Liraglutide Injection Sales Volume by Application
  5. 5.2.1 Global Liraglutide Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Liraglutide Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Liraglutide Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Liraglutide Injection Sales Value by Application
  9. 5.3.1 Global Liraglutide Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Liraglutide Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Liraglutide Injection Sales Value Share by Application (2021-2032)
6 Liraglutide Injection Regional Sales and Value Analysis
  1. 6.1 Global Liraglutide Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liraglutide Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Liraglutide Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Liraglutide Injection Sales by Region (2027-2032)
  5. 6.3 Global Liraglutide Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Liraglutide Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Liraglutide Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Liraglutide Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Liraglutide Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Liraglutide Injection Sales Value (2021-2032)
  12. 6.6.2 North America Liraglutide Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Liraglutide Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Liraglutide Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Liraglutide Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Liraglutide Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Liraglutide Injection Sales Value (2021-2032)
  21. 6.9.2 South America Liraglutide Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Liraglutide Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Liraglutide Injection Sales Value Share by Country, 2025 VS 2032
7 Liraglutide Injection Country-level Sales and Value Analysis
  1. 7.1 Global Liraglutide Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liraglutide Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Liraglutide Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Liraglutide Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Liraglutide Injection Sales by Country (2027-2032)
  6. 7.4 Global Liraglutide Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Liraglutide Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Liraglutide Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Liraglutide Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Liraglutide Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Liraglutide Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Liraglutide Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Liraglutide Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Liraglutide Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Liraglutide Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Liraglutide Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Liraglutide Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Liraglutide Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Liraglutide Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Liraglutide Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Liraglutide Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Liraglutide Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Liraglutide Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Liraglutide Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Liraglutide Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Liraglutide Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Liraglutide Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Liraglutide Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Liraglutide Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Liraglutide Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Liraglutide Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Liraglutide Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Liraglutide Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Liraglutide Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Liraglutide Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Liraglutide Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Liraglutide Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Liraglutide Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Liraglutide Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Liraglutide Injection Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Liraglutide Injection Value Chain Analysis
  2. 9.1.1 Liraglutide Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Liraglutide Injection Sales Mode & Process
  6. 9.2 Liraglutide Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Liraglutide Injection Distributors
  9. 9.2.3 Liraglutide Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst